Paragon Genomics specializes in providing high-performance targeted sequencing solutions powered by its proprietary CleanPlex® technology. This ultra-high multiplex PCR-based approach facilitates efficient and accurate DNA and RNA sequencing, catering to a wide range of applications including precision oncology, infectious disease research, inherited disease testing, and agrigenomics. The CleanPlex® system boasts a streamlined workflow that delivers sequencing-ready libraries in approximately three hours, even from challenging samples like degraded FFPE tissues or low-input DNA. It supports both ready-to-use panels and fully customizable NGS assays, allowing researchers to design panels targeting specific genomic regions of interest. Additionally, Paragon Genomics offers comprehensive services encompassing DNA and mRNA sequencing, bioinformatics consultation, and OEM solutions, all compatible with major sequencing platforms such as Illumina and Ion Torrent.

CD Genomics is providing accurate and reliable HLA genotyping service using next-generation sequencing (NGS) technology by generating unambiguous, phase-resolved HLA sequencing results in a single assay.

CD Genomics’s Single-Cell Sequencing conference focuses on the links between cell variation in tissues and organ function and further elucidates the origins of diseases.

CD genomics provides a ribosome-profiling strategy that is based on the deep sequencing of ribosome-protected mRNA fragments and enables genome-wide investigation of translation with sub cordon resolution. Using nuclease digestion, the ribosome posit

Creative Biolabs is gladly to show a series of unrivalled de novo antibody sequencing services for research, diagnostic and therapeutic industries.